Pinnacle Financial Partners (Georgia)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Sell
34,932
-141
-0.4% -$6.06K 0.01% 530
2026
Q1
$1.29M Buy
35,073
+4,190
+14% +$199K 0.01% 544
2025
Q4
$1.57M Buy
+30,883
New +$1.58M 0.01% 505

Other funds holding NVO

Pinnacle Financial Partners (Georgia)'s NVO Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its Novo Nordisk (NVO) stake by 0.4% in Q2 2026, selling an estimated $6.06K and leaving 34,932 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #530.

Pinnacle Financial Partners (Georgia) first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 34,932 shares of Novo Nordisk worth $1.67M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 141 Novo Nordisk shares in Q2 2026, an estimated $6.06K.
  • Novo Nordisk made up 0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #530 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.